St. Jude Medical Receives FDA Approval For Accent RF, Anthem RF CRT- Pacemakers Using Wireless Technology

St. Jude Medical, Inc. (St. Jude Medical) announced that US Food and Drug Administration (FDA) approved its Accent RF pacemaker and Anthem RF cardiac resynchronization therapy pacemaker (RF CRT-P) that simplify patient management. The company also received FDA and European CE Mark approval for version 4.0 of Merlin.net Patient Care Network (PCN), which supports the Accent RF and Anthem RF devices.